COMMUNIQUÉS West-GlobeNewswire

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

10/06/2024 - 22:54

Iqirvo ® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver disease called primary biliary cholangitis Approval based on positive Phase III ELATIVE [...]

Le médicament Iqirvo® d’Ipsen obtient l’approbation de la FDA via une procédure accélérée comme traitement PPAR premier de sa classe thérapeutique pour la cholangite biliaire primitive

10/06/2024 - 22:54

Iqirvo® (elafibranor) 80 mg comprimés est le premier nouveau médicament approuvé depuis près de dix ans pour le traitement d’une maladie hépatique rare appelée cholangite biliaire primitive. L’approbation a été accordée [...]

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

10/06/2024 - 22:15

WINSTON-SALEM, N.C., June 10, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today [...]

Sight Sciences Announces the Release of its First Sustainability Report

10/06/2024 - 22:05

The Sustainability Report provides data for 2021 through 2023 on the Company’s environmental, social, and governance initiatives MENLO PARK, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT [...]

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

10/06/2024 - 20:33

LONDON, Ontario, June 10, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals presented notable pre-clinical data about its lead compound, LRP-661, also known as Cannabidiol Sulphate (CBDS), at the [...]

Arcutis Announces New Long-Term Data of Roflumilast Cream 0.15% for the Treatment of Mild to Moderate Atopic Dermatitis (AD) in Adults and Children Down to Age Six Presented at Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference

10/06/2024 - 20:30

Investigational roflumilast cream 0.15% showed continued improvements in the signs and symptoms of AD, including itch, through 56 weeks of treatment 66.2% of participants treated with once-daily roflumilast cream 0.15% [...]

UPDATED MEDIA ADVISORY: Updated list of Public Hearings re. Public Hearings across Ontario to protect & restore local public hospitals

10/06/2024 - 18:56

TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- In response to more than 1,200 closures of emergency departments and other local hospital services over the last year , the Ontario Health Coalition (OHC) is holding public [...]

Partnership of Spineway with the SFCR for June 24 congress

10/06/2024 - 18:00

Press release Ecully, June 10, 2024 – 6 p.m. SPINEWAY partners with the Société Française de Chirurgie du Rachis (SFCR) Congress in Montpellier, France The Spineway Group, a specialist in innovative implants for the [...]

SPINEWAY partenaire de la SFCR lors du congrès de Juin 2024

10/06/2024 - 18:00

Communiqué de presse Ecully, le 10 juin 2024 – 18h SPINEWAY sera partenaire du congrès de la Société Française de Chirurgie du Rachis (SFCR) à Montpellier Le groupe Spineway spécialiste des implants innovants pour le [...]

Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.

10/06/2024 - 17:49

Stocking of GLOPERBA ® is underway in all of the wholesalers with which Scilex has stocking arrangements throughout the U.S and Scilex expects completion of stocking by Wednesday June 12, 2024. Today, Scilex is [...]

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

10/06/2024 - 16:50

Rutherford, NJ, June 10, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel [...]

Transactions in Connection with Share Buy-back Program

10/06/2024 - 16:18

Company Announcement COPENHAGEN, Denmark; June 10, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. [...]

BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

10/06/2024 - 15:45

Westport, CT, June 10, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or "Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal [...]

Palisade Bio to Present at the Virtual Investor Pitch Conference

10/06/2024 - 15:15

Live video webcast on Monday, June 17 th at 12:00 PM ET Carlsbad, CA, June 10, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing [...]

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

10/06/2024 - 15:10

DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable [...]

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

10/06/2024 - 15:05

ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA SAN DIEGO, June 10, [...]

TOMI Environmental Solutions Secures Two New Purchase Agreements with Leading Pharmaceutical Companies

10/06/2024 - 15:00

FREDERICK, Md., June 10, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization [...]

TerrAscend Celebrates Opening of The Apothecarium Nottingham, Maryland Dispensary

10/06/2024 - 15:00

Prime location features a convenient drive-thru and an expanded floor plan TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American [...]

SFWJ/MedCana Announces Significant Progress Across Its Operations, Eyes Global Expansion and Enhanced Profitability

10/06/2024 - 15:00

AUSTIN, Texas, June 10, 2024 (GLOBE NEWSWIRE) -- via IBN – SFWJ, doing business as MedCana, a leading entity in the cannabis and agricultural technology sectors, unveils its strategic initiative as the Company embarks [...]